Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Silver

Showing results (111-120 of 232) with videos related to

Pageof 24
Sort By:
Leukemia Research|October 11, 2011
Treatment of polycythemia vera with imatinib mesylateRichard T Silver, Michael H Bourla, Katherine Vandris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1983
Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B studyM Green, C Horton, M Spaulding, et al.
Leukemia|July 1, 1995
Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group BK R Rai, F Davey, B Peterson, et al.
Blood Advances|March 20, 2024
Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomesReem S Chamseddine, Oleksandr Savenkov, Shehroz Rana, et al.
Leukemia Research|July 24, 2010
JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapyRichard T Silver, Katherine Vandris, Y Lynn Wang, et al.
Archives of Internal Medicine|April 1, 1978
Fever, rash, and muscle tenderness. A distinctive clinical presentation of disseminated candidiasisC I Jarowski, M A Fialk, H W Murray, et al.
Clinical Immunology (Orlando, Fla.)|November 23, 2006
Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia veraZeyu Xiong, Yan Yan, Enli Liu, et al.
Cancer|October 1, 1987
A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group BR T Silver, R Mick, R Cooper, et al.
Toxicology and Applied Pharmacology|October 1, 1986
Immunotoxicity studies in mice exposed to methyl isocyanateM I Luster, A N Tucker, D R Germolec, et al.
Leukemia Research|July 6, 2004
The second international congress on myeloproliferative and myelodysplastic syndromesR T Silver, J M Bennett, M Deininger, et al.
Pageof 24

Showing results (111-120 of 232) with videos related to

Sort By:
Pageof 24
Leukemia Research|October 11, 2011
Treatment of polycythemia vera with imatinib mesylateRichard T Silver, Michael H Bourla, Katherine Vandris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1983
Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B studyM Green, C Horton, M Spaulding, et al.
Leukemia|July 1, 1995
Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group BK R Rai, F Davey, B Peterson, et al.
Blood Advances|March 20, 2024
Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomesReem S Chamseddine, Oleksandr Savenkov, Shehroz Rana, et al.
Leukemia Research|July 24, 2010
JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapyRichard T Silver, Katherine Vandris, Y Lynn Wang, et al.
Archives of Internal Medicine|April 1, 1978
Fever, rash, and muscle tenderness. A distinctive clinical presentation of disseminated candidiasisC I Jarowski, M A Fialk, H W Murray, et al.
Clinical Immunology (Orlando, Fla.)|November 23, 2006
Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia veraZeyu Xiong, Yan Yan, Enli Liu, et al.
Cancer|October 1, 1987
A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group BR T Silver, R Mick, R Cooper, et al.
Toxicology and Applied Pharmacology|October 1, 1986
Immunotoxicity studies in mice exposed to methyl isocyanateM I Luster, A N Tucker, D R Germolec, et al.
Leukemia Research|July 6, 2004
The second international congress on myeloproliferative and myelodysplastic syndromesR T Silver, J M Bennett, M Deininger, et al.
Pageof 24